Michael Stotz
Impact in
- Oncology top 1%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
- Oncology 45
- Inflammatory Biomarkers in Disease Prognosis 23
- Pancreatic and Hepatic Oncology Research 14
- Cancer Immunotherapy and Biomarkers 8
-
- Cancer, Lipids, and Metabolism 8
- Co-authors
- Armin GergerMartin PichlerJoanna SzkanderaTatjana StojakovićGudrun AbsengerRenate Schaberl-MoserH. SamoniggHellmut Samonigg
- Journals
- British Journal of Cancer (8 papers)PLoS ONE (5 papers)Anticancer Research (4 papers)International Journal of Molecular Sciences (4 papers)Clinical & Translational Oncology (3 papers)
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Michael Stotz
71 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 2.2k
- Cancer Research 901
- Pulmonary and Respiratory Medicine 738
- Internal Medicine 79
- Surgery 845
Countries citing papers authored by Michael Stotz
This map shows the geographic impact of Michael Stotz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stotz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stotz more than expected).
Fields of papers citing papers by Michael Stotz
This network shows the impact of papers produced by Michael Stotz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stotz. The network helps show where Michael Stotz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Stotz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2021 | 19 | |
| 3 | 2021 | 37 | |
| 4 | 2020 | 2 | |
| 5 | 2019 | 7 | |
| 6 | 2018 | 12 | |
| 7 | 2017 | 9 | |
| 8 | 2017 | 18 | |
| 9 | 2017 | 6 | |
| 10 | 2015 | 12 | |
| 11 | 2014 | 40 | |
| 12 | 2014 | 42 | |
| 13 | 2013 | 12 | |
| 14 | 2013 | 162 | |
| 15 | 2013 | 11 | |
| 16 | 2013 | 16 | |
| 17 | 2013 | 86 | |
| 18 | 2012 | 24 | |
| 19 | 2012 | 78 | |
| 20 | 2010 | 39 |
About Michael Stotz
Michael Stotz is a scholar working on Oncology, Cancer Research, Internal Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 3.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (23 papers), Pancreatic and Hepatic Oncology Research (14 papers), Sarcoma Diagnosis and Treatment (12 papers), Cancer, Lipids, and Metabolism (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal and Anal Carcinomas (7 papers), Testicular diseases and treatments (6 papers) and Pancreatitis Pathology and Treatment (5 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (901 citations), Pulmonary and Respiratory Medicine (738 citations), Internal Medicine (79 citations) and Surgery (845 citations). Michael Stotz has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Armin Gerger, Martin Pichler, Joanna Szkandera, Tatjana Stojaković, Gudrun Absenger, Renate Schaberl-Moser, H. Samonigg, Hellmut Samonigg, Peter Kornprat and Gerald Höefler. Their work appears in journals such as British Journal of Cancer, PLoS ONE, Anticancer Research, International Journal of Molecular Sciences and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.